Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy

  • Authors:
    • Xinlin Wu
    • Miansheng Yan
    • Taoli Liu
    • Jiantang Liao
    • Jianqing Zhang
    • Shuqing Chen
    • Wei Deng
    • Shijun Zhang
    • Baoguo Sun
    • Houming Zhou
    • Bin Ke
  • View Affiliations / Copyright

    Affiliations: Department of Traditional Chinese Medicine, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China, Department of Traditional Chinese Medicine, The Fifth Affiliated Hospital of Sun Yat‑sen University, Zhuhai, Guangdong 519000, P.R. China, Community Health Service Center of Dongshan, Guangzhou, Guangdong 510030, P.R. China
    Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4153-4159
    |
    Published online on: August 30, 2017
       https://doi.org/10.3892/etm.2017.5077
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Uric acid nephropathy (UAN) is caused by excessive uric acid, and is a key risk factor for uric acid nephrolithiasis, gouty arthritis, renal diseases and cardiovascular diseases. The present study aimed to evaluate the protective effect of fucoidan, a sulfated polysaccharide component of brown algae, on UAN and to elucidate the underlying molecular mechanism. A rat model of UAN was induced by adenine treatment, and rats were then randomly assigned to control, model or fucoidan treatment groups. Hematoxylin and eosin staining of the kidney tissues of rats with UAN was subjected to conventional morphological evaluation. Cellular infiltrate in the tubules, atrophic glomeruli, tubular ectasia, granuloma hyperplasia focal fibrosis and accumulated urate crystals in the tubules of UAN rat renal tissues were observed. These symptoms of kidney damage were reduced in the fucoidan treatment group. Periodic acid methenamine silver‑Masson staining was performed and the results indicated that renal interstitial fibrosis was reduced among renal tissues from the fucoidan treatment group compared with the model group. Terminal deoxynucleotidyl‑transferase‑mediated dUTP nick end labelling staining revealed a lower proportion of apoptotic nuclei in the kidneys of the fucoidan treatment group compared with the model group. Protein kinase A (PKA) 2β and phosphorylated PKA 2β protein levels were significantly elevated in renal tissues of the fucoidan treatment group compared with the model group (P<0.05 and P<0.01, respectively), suggesting that PKA expression was upregulated by fucoidan. Immunohistochemistry staining of PKA in rat renal tissues demonstrated increased expression of PKA. The surface organic cation transporter 2 (OCT2) level was significantly increased by fucoidan treatment compared with the model group (P<0.01), with no significant change in total OCT2 level. COS‑7 cells ectopically expressing OCT2 were established. It was indicated that fucoidan was able to activate PKA and upregulate surface OCT2 in OCT2‑expressing COS‑7 cells. This further demonstrated that upregulation of surface OCT2 expression in OCT2‑expressing cells was induced by PKA upregulation. In conclusion, fucoidan upregulated surface OCT2 expression in renal tissues to alleviate the symptoms of UAN via upregulated expression of PKA.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Cunha L and Grenha A: Sulfated seaweed polysaccharides as multifunctional materials in drug delivery applications. Mar Drugs. 14:pii: E42. 2016. View Article : Google Scholar : PubMed/NCBI

2 

de Souza Rocha MC, Marques CT, Dore Guerra CM, da Silva Ferreira FR, Rocha Oliveira HA and Leite EL: Antioxidant activities of sulfated polysaccharides from brown and red seaweeds. J Appl Phycol. 19:153–160. 2007. View Article : Google Scholar : PubMed/NCBI

3 

Fitton JH, Stringer DN and Karpiniec SS: Therapies from Fucoidan: An update. Mar Drugs. 13:5920–5946. 2015. View Article : Google Scholar : PubMed/NCBI

4 

Hayashi S, Itoh A, Isoda K, Kondoh M, Kawase M and Yagi K: Fucoidan partly prevents CCl4-induced liver fibrosis. Eur J Pharmacol. 580:380–384. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Kuznetsova TA, Besednova NN, Mamaev AN, Momot AP, Shevchenko NM and Zvyagintseva TN: Anticoagulant activity of fucoidan from brown algae Fucus evanescens of the Okhotsk Sea. Bull Exp Biol Med. 136:471–473. 2003. View Article : Google Scholar : PubMed/NCBI

6 

Koyanagi S, Tanigawa N, Nakagawa H, Soeda S and Shimeno H: Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol. 65:173–179. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Wang J, Liu H, Li N, Zhang Q and Zhang H: The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy. Mar Drugs. 12:3292–3306. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Veena CK, Josephine A, Preetha SP, Varalakshmi P and Sundarapandiyan R: Renal peroxidative changes mediated by oxalate: The protective role of fucoidan. Life Sci. 79:1789–1795. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Zhang Q, Li N, Zhao T, Qi H, Xu Z and Li Z: Fucoidan inhibits the development of proteinuria in active Heymann nephritis. Phytother Res. 19:50–53. 2005. View Article : Google Scholar : PubMed/NCBI

10 

Zhang Q, Li Z, Xu Z, Niu X and Zhang H: Effects of fucoidan on chronic renal failure in rats. Planta Med. 69:537–541. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Veena CK, Josephine A, Preetha SP and Varalakshmi P: Physico-chemical alterations of urine in experimental hyperoxaluria: A biochemical approach with fucoidan. J Pharm Pharmacol. 59:419–427. 2007. View Article : Google Scholar : PubMed/NCBI

12 

Okuda M, Saito H, Urakami Y, Takano M and Inui K: cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem Biophys Res Commun. 224:500–507. 1996. View Article : Google Scholar : PubMed/NCBI

13 

Karbach U, Kricke J, Meyer-Wentrup F, Gorboulev V, Volk C, Loffing-Cueni D, Kaissling B, Bachmann S and Koepsell H: Localization of organic cation transporters OCT1 and OCT2 in rat kidney. Am J Physiol Renal Physiol. 279:F679–F687. 2000.PubMed/NCBI

14 

Muller F and Fromm MF: Transporter-mediated drug-drug interactions. Pharmacogenomics. 12:1017–1037. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Wilde S, Schlatter E, Koepsell H, Edemir B, Reuter S, Pavenstadt H, Neugebauer U, Schroter R, Brast S and Ciarimboli G: Calmodulin-associated post-translational regulation of rat organic cation transporter 2 in the kidney is gender dependent. Cell Mol Life Sci. 66:1729–1740. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Wu YR, Qi HJ, Deng DF, Luo YY and Yang SL: MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer. Tumour Biol. 37:12061–12070. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Djordjevic B, Hennessy BT, Li J, Barkoh BA, Luthra R, Mills GB and Broaddus RR: Clinical assessment of PTEN loss in endometrial carcinoma: Immunohistochemistry outperforms gene sequencing. Mod Pathol. 25:699–708. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Zhang Q, Li S, Patterson C and You G: Lysine 48-linked polyubiquitination of organic anion transporter-1 is essential for its protein kinase C-regulated endocytosis. Mol Pharmacol. 83:217–224. 2013. View Article : Google Scholar : PubMed/NCBI

19 

Holle SK, Ciarimboli G, Edemir B, Neugebauer U, Pavenstadt H and Schlatter E: Properties and regulation of organic cation transport in freshly isolated mouse proximal tubules analyzed with a fluorescence reader-based method. Pflugers Arch. 462:359–369. 2011. View Article : Google Scholar : PubMed/NCBI

20 

Soodvilai S, Chatsudthipong A and Chatsudthipong V: Role of MAPK and PKA in regulation of rbOCT2-mediated renal organic cation transport. Am J Physiol Renal Physiol. 293:F21–F27. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Klemp P, Stansfield SA, Castle B and Robertson MC: Gout is on the increase in New Zealand. Ann Rheum Dis. 56:22–26. 1997. View Article : Google Scholar : PubMed/NCBI

22 

Arromdee E, Michet CJ, Crowson CS, O'Fallon WM and Gabriel SE: Epidemiology of gout: Is the incidence rising? J Rheumatol. 29:2403–2406. 2002.PubMed/NCBI

23 

Li Y, Stamler J, Xiao Z, Folsom A, Tao S and Zhang H: Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing. The PRC-USA collaborative study in cardiovascular and cardiopulmonary epidemiology. Int J Epidemiol. 26:288–296. 1997. View Article : Google Scholar : PubMed/NCBI

24 

Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J and Mazzali M: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 41:1183–1190. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Tseng CH: Independent association of uric acid levels with peripheral arterial disease in Taiwanese patients with Type 2 diabetes. Diabet Med. 21:724–729. 2004. View Article : Google Scholar : PubMed/NCBI

26 

Shanley PF, Rosen MD, Brezis M, Silva P, Epstein FH and Rosen S: Topography of focal proximal tubular necrosis after ischemia with reflow in the rat kidney. Am J Pathol. 122:462–468. 1986.PubMed/NCBI

27 

Soeda S, Kozako T, Iwata K and Shimeno H: Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: Its possible mechanism of action. Biochim Biophys Acta. 1497:127–134. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Lee JB, Hayashi K, Hashimoto M, Nakano T and Hayashi T: Novel antiviral fucoidan from sporophyll of Undaria pinnatifida (Mekabu). Chem Pharm Bull (Tokyo). 52:1091–1094. 2004. View Article : Google Scholar : PubMed/NCBI

29 

Raghavendran HR, Srinivasan P and Rekha S: Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Int Immunopharmacol. 11:157–163. 2011. View Article : Google Scholar : PubMed/NCBI

30 

Teng H, Yang Y, Wei H, Liu Z, Liu Z, Ma Y, Gao Z, Hou L and Zou X: Fucoidan suppresses Hypoxia-Induced lymphangiogenesis and lymphatic metastasis in mouse hepatocarcinoma. Mar Drugs. 13:3514–3530. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Sweet DH, Miller DS and Pritchard JB: Basolateral localization of organic cation transporter 2 in intact renal proximal tubules. Am J Physiol Renal Physiol. 279:F826–F834. 2000.PubMed/NCBI

32 

Terashita S, Dresser MJ, Zhang L, Gray AT, Yost SC and Giacomini KM: Molecular cloning and functional expression of a rabbit renal organic cation transporter. Biochim Biophys Acta. 1369:1–6. 1998. View Article : Google Scholar : PubMed/NCBI

33 

Grundemann D, Babin-Ebell J, Martel F, Ording N, Schmidt A and Schomig E: Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J Biol Chem. 272:10408–10413. 1997. View Article : Google Scholar : PubMed/NCBI

34 

Cetinkaya I, Ciarimboli G, Yalcinkaya G, Mehrens T, Velic A, Hirsch JR, Gorboulev V, Koepsell H and Schlatter E: Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases. Am J Physiol Renal Physiol. 284:F293–F302. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wu X, Yan M, Liu T, Liao J, Zhang J, Chen S, Deng W, Zhang S, Sun B, Zhou H, Zhou H, et al: Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy. Exp Ther Med 14: 4153-4159, 2017.
APA
Wu, X., Yan, M., Liu, T., Liao, J., Zhang, J., Chen, S. ... Ke, B. (2017). Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy. Experimental and Therapeutic Medicine, 14, 4153-4159. https://doi.org/10.3892/etm.2017.5077
MLA
Wu, X., Yan, M., Liu, T., Liao, J., Zhang, J., Chen, S., Deng, W., Zhang, S., Sun, B., Zhou, H., Ke, B."Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy". Experimental and Therapeutic Medicine 14.5 (2017): 4153-4159.
Chicago
Wu, X., Yan, M., Liu, T., Liao, J., Zhang, J., Chen, S., Deng, W., Zhang, S., Sun, B., Zhou, H., Ke, B."Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4153-4159. https://doi.org/10.3892/etm.2017.5077
Copy and paste a formatted citation
x
Spandidos Publications style
Wu X, Yan M, Liu T, Liao J, Zhang J, Chen S, Deng W, Zhang S, Sun B, Zhou H, Zhou H, et al: Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy. Exp Ther Med 14: 4153-4159, 2017.
APA
Wu, X., Yan, M., Liu, T., Liao, J., Zhang, J., Chen, S. ... Ke, B. (2017). Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy. Experimental and Therapeutic Medicine, 14, 4153-4159. https://doi.org/10.3892/etm.2017.5077
MLA
Wu, X., Yan, M., Liu, T., Liao, J., Zhang, J., Chen, S., Deng, W., Zhang, S., Sun, B., Zhou, H., Ke, B."Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy". Experimental and Therapeutic Medicine 14.5 (2017): 4153-4159.
Chicago
Wu, X., Yan, M., Liu, T., Liao, J., Zhang, J., Chen, S., Deng, W., Zhang, S., Sun, B., Zhou, H., Ke, B."Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4153-4159. https://doi.org/10.3892/etm.2017.5077
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team